Evidence map›Paper›PMID 26032049›Full record

ArticleClinical and experimental immunology2015

Bioenergetic analysis of human peripheral blood mononuclear cells.

N Jones, J Piasecka, A H Bryant, R H Jones, D O F Skibinski, Nigel J Francis, C A Thornton

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Peripheral immune-cell bioenergetics in acute and stable schizophrenia.European archives of psychiatry and clinical neuroscience · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Bio-protocol · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

N JonesInstitute of Life Science, College of Medicine, Swansea University, Swansea, UK.
J PiaseckaInstitute of Life Science, College of Medicine, Swansea University, Swansea, UK.
A H BryantInstitute of Life Science, College of Medicine, Swansea University, Swansea, UK.
R H JonesInstitute of Life Science, College of Medicine, Swansea University, Swansea, UK.
D O F SkibinskiInstitute of Life Science, College of Medicine, Swansea University, Swansea, UK.
Nigel J FrancisInstitute of Life Science, College of Medicine, Swansea University, Swansea, UK.
C A ThorntonInstitute of Life Science, College of Medicine, Swansea University, Swansea, UK.
Swansea University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leucocytes respond rapidly to pathogenic and other insults, with responses ranging from cytokine production to migration and phagocytosis. These are bioenergetically expensive, and increased glycolytic flux provides adenosine triphosphate (ATP) rapidly to support these essential functions. However, much of this work is from animal studies. To understand more clearly the relative role of glycolysis and oxidative phosphorylation in human leucocytes, especially their utility in a translational research setting, we undertook a study of human peripheral blood mononuclear cells (MNCs) bioenergetics. Glycolysis was essential during lipopolysaccharide (LPS)-mediated interleukin (IL)-1β, IL-6 and tumour necrosis factor (TNF)-α production, as 2-deoxy-D-glucose decreased significantly the output of all three cytokines. After optimizing cell numbers and the concentrations of all activators and inhibitors, oxidative phosphorylation and glycolysis profiles of fresh and cryopreserved/resuscitated MNCs were determined to explore the utility of MNCs for determining the bioenergetics health profile in multiple clinical settings. While the LPS-induced cytokine response did not differ significantly between fresh and resuscitated cells from the same donors, cryopreservation/resuscitation significantly affected mainly some measures of oxidative phosphorylation, but also glycolysis. Bioenergetics analysis of human MNCs provides a quick, effective means to measure the bioenergetics health index of many individuals, but cryopreserved cells are not suitable for such an analysis. The translational utility of this approach was tested by comparing MNCs of pregnant and non-pregnant women to reveal increased bioenergetics health index with pregnancy but significantly reduced basal glycolysis and glycolytic capacity. More detailed analysis of discrete leucocyte populations would be required to understand the relative roles of glycolysis and oxidative phosphorylation during inflammation and other immune responses.

Indexed as

Adenosine TriphosphateAdultAntimetabolitesCells, CulturedCryopreservationDeoxyglucoseFemaleGlycolysisHumansInterleukin-1betaInterleukin-6Leukocytes, MononuclearLipopolysaccharidesL-Lactate DehydrogenaseOxidative PhosphorylationPregnancyAdenosine TriphosphateAntimetabolitesDeoxyglucoseIL1B protein, humanIL6 protein, humanInterleukin-1betaInterleukin-6LipopolysaccharidesL-Lactate DehydrogenaseTumor Necrosis Factor-alphacell activationcytokineshumaninflammation

Identifiers

PMID26032049
PMCPMC4578510
OpenAlexW2130552395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.